Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 3284 entries
View as:

AZD8683 Single Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00979849 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00232648 Org: User:
Start: 01/31/04 End: 11/30/06 Due: 11/30/07

Iressa Expanded Access Program (EAP)

Phase: N/A Priority: Normal
NCT ID: NCT00034879 Org: User:
Start: 08/31/00 End: 10/31/03 Due: 10/31/04

Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01232335 Org: User:
Start: 01/31/10 End: 05/31/13 Due: 05/31/14

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00870194 Org: User:
Start: 03/31/09 End: 04/30/10 Due: 04/30/11

Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)

Phase: N/A Priority: Normal
NCT ID: NCT00659503 Org: User:
Start: 02/28/05 End: 11/30/05 Due: 11/30/06

A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended

Phase: N/A Priority: Normal
NCT ID: NCT00922090 Org: User:
Start: 07/31/09 End: 01/31/10 Due: 01/31/11

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00701935 Org: User:
Start: 08/31/08 End: 01/31/12 Due: 01/31/13

Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France

Phase: N/A Priority: Normal
NCT ID: NCT01552005 Org: User:
Start: 05/31/12 End: 06/30/15 Due: 06/30/16

Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)

Phase: N/A Priority: Normal
NCT ID: NCT00882128 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres

Phase: N/A Priority: Normal
NCT ID: NCT05932849 Org: User:
Start: 10/05/21 End: 02/28/22 Due: 02/28/23

Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy

Phase: N/A Priority: Normal
NCT ID: NCT01961349 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Phase: N/A Priority: Normal
NCT ID: NCT05489211 Org: User:
Start: 09/06/22 End: 08/19/26 Due: 08/19/27

Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT04890548 Org: User:
Start: 11/23/21 End: 08/02/22 Due: 08/02/23

A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01219946 Org: User:
Start: 10/31/10 End: 03/31/11 Due: 03/31/12

Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01435525 Org: User:
Start: 09/30/11 End: 03/31/14 Due: 03/31/15

Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00107107 Org: User:
Start: 11/30/02 End: 06/30/05 Due: 06/30/06

Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00319618 Org: User:
Start: 06/30/03 End: 06/30/06 Due: 06/30/07

AZD8186 First Time In Patient Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01884285 Org: User:
Start: 07/09/13 End: 02/07/20 Due: 02/07/21

Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)

Phase: N/A Priority: Normal
NCT ID: NCT02060201 Org: User:
Start: 02/28/14 End: 05/31/14 Due: 05/31/15

A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00917267 Org: User:
Start: 07/31/09 End: 04/30/11 Due: 04/30/12

Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00530699 Org: User:
Start: 11/30/07 End: 08/31/09 Due: 08/31/10

Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02341456 Org: User:
Start: 01/16/15 End: 07/09/18 Due: 07/09/19

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02207530 Org: User:
Start: 10/23/14 End: 07/06/20 Due: 07/06/21

Symbicort Rapihaler Therapeutic Equivalence Study

Phase: N/A Priority: Normal
NCT ID: NCT00536731 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09